Subscribe

California Nanotechnologies Corp. (CANOF)

USD0.26 +0.01 (+5.26%)
US OTC Basic Materials Chemicals - Specialty
Address 17220 Edwards Road 90703
Cerritos, CA, US
CEO Eric Eyerman
IPO 2014-10-31
ISIN CA1304921010

Explore sections of this company profile

Also trades on Other OTC · CANOF (USD) Toronto Stock Exchange Ventures · CNO.V (CAD)
Description

California Nanotechnologies Corp. specializes in the research, development, and manufacturing of nano-structured components and advanced materials. The company offers a comprehensive suite of services, encompassing advanced material processing techniques such as spark plasma sintering (SPS), cryogenic milling, and wire electrical discharge machining. They also perform various milling operations (planetary, ball, V-blending/tumble), undertake hot pressing tooling fabrication and design, and provide machining for metals and metallic alloys. Furthermore, their capabilities include material characterization via particle size analysis (using laser diffraction) and mechanical testing (tensile, compression, and hardness). In addition to services, their product portfolio includes SPS starter accessory kits, graphite and tungsten carbide tooling, graphite crucibles, and spark plasma sintering machines, alongside carbon graphite foil/paper, carbon felt, yarn, and quartz glass windows. Their diverse clientele spans critical sectors including microchip manufacturing, aerospace, defense, automotive, medical, oil and gas, and sports and recreation. The company's operations are based in Cerritos, California.

News Sentiment (7d)
50 Neutral

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.26 +0.01 (+5.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
26.4K
Beta
1.18
Float Shares
32.97M
Free Float %
68.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+7.68% -13.49% -2.97% -15.47% -21.00% -23.46% -54.76% +47.19% +156.50% +207.64% +397.01%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.26
DCF (Unlevered) 1.80 +595.5%
DCF (Levered) 2.52 +873.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-0.12
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    -54.5% Q1'26: -17.5% (vs Q1'25)
  • EPS growth Chemicals - Specialty: +13.2%
    -1,120.6% Q1'26: +107.1% (vs Q1'25)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -45.3% Q1'26: +0.6% (vs Q1'25)
  • EBIT margin Chemicals - Specialty: +8.8%
    -71.5% Q1'26: -41.9% (vs Q1'25)
  • ROIC Chemicals - Specialty: +5.6%
    -65.9% Q1'26: -51.5% (vs Q1'25)
  • Share dilution Chemicals - Specialty: +0.1%
    +1.1% Q1'26: +5.7% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    -0.99× Q1'26: -1.49× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.09) × ERP
WACC = 84% × Ke + 16% × Kd (11.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1.80 Current price: 0.26
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Feb 2026
1 Rev. Ana.
1 EPS Ana.
Feb 2027
1 Rev. Ana.
1 EPS Ana.
Feb 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
2.70M
2.70M – 2.70M
2.21M
2.21M – 2.21M
-18.2% YoY
3.65M
3.65M – 3.65M
+65.0% YoY
EBITDA
612.5K
612.5K – 612.5K
501.0K
501.0K – 501.0K
-18.2% YoY
826.6K
826.6K – 826.6K
+65.0% YoY
EBIT
312.8K
312.8K – 312.8K
255.9K
255.9K – 255.9K
-18.2% YoY
422.1K
422.1K – 422.1K
+65.0% YoY
Net Income
-2.25M
-2.25M – -2.25M
-1.73M
-1.73M – -1.73M
+23.2% YoY
-865.5K
-865.5K – -865.5K
+50.0% YoY
SGA
985.6K
985.6K – 985.6K
806.2K
806.2K – 806.2K
-18.2% YoY
1.33M
1.33M – 1.33M
+65.0% YoY
EPS
-0.05
-0.05 – -0.05
-0.04
-0.04 – -0.04
+23.2% YoY
-0.02
-0.02 – -0.02
+50.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-27 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-26 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-22 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-1.53M
OE per share TTM
-0.03
Owner's Yield
-16.84%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
46.5%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-101.3K
Shares Outstanding
47.88M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Eric Eyerman Chief Executive Officer & Director 485.4K male
Christopher Trenton Melnyk Chief Technology Officer 267.3K male
Roger Dent Interim Chief Financial Officer & Director 47.1K male
Spencer Song Vice President of Operations male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits